US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.440
- +0.060+4.35%
Close Dec 27 16:00 ET
- 1.440
- 0.000-0.01%
Post 20:01 ET
43.03MMarket Cap-0.72P/E (TTM)
1.450High1.390Low154.71KVolume1.390Open1.380Pre Close219.77KTurnover1.04%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.49P/B21.52MFloat Cap0.87052wk Low--Dividend TTM14.94MShs Float23.580Historical High--Div YieldTTM4.35%Amplitude0.870Historical Low1.420Avg Price1Lot Size
AN2 Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -24.55%93.43M | 9.74%104.54M | 29.03%114.21M | 11.70%107.3M | 11.70%107.3M | 18.62%123.82M | -15.99%95.26M | -25.21%88.52M | 64.05%96.06M | 64.05%96.06M |
| -Cash and cash equivalents | 2.72%33.5M | -34.41%26.77M | -7.55%24.69M | -42.51%15.65M | -42.51%15.65M | 13.24%32.62M | 0.48%40.81M | -67.63%26.71M | 125.01%27.22M | 125.01%27.22M |
| -Short-term investments | -34.30%59.92M | 42.84%77.77M | 44.84%89.52M | 33.13%91.65M | 33.13%91.65M | 20.67%91.2M | -25.18%54.45M | 72.47%61.81M | 48.18%68.84M | 48.18%68.84M |
| Other current assets | 64.53%4.26M | -1.70%2.9M | 16.77%2.1M | 25.37%3.21M | 25.37%3.21M | -11.08%2.59M | -15.48%2.95M | 26.03%1.8M | 65.18%2.56M | 65.18%2.56M |
| Total current assets | -22.72%97.69M | 9.40%107.44M | 28.78%116.31M | 12.05%110.51M | 12.05%110.51M | 17.81%126.41M | -15.97%98.21M | -24.60%90.32M | 64.08%98.62M | 64.08%98.62M |
| Non current assets | ||||||||||
| Investments and advances | --0 | --0 | --3.9M | 744.80%27.19M | 744.80%27.19M | 1,223.09%26.36M | --0 | --0 | -7.66%3.22M | -7.66%3.22M |
| Non current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --48K | ---- | ---- |
| Other non current assets | ---- | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 0.00%720K | 0.00%720K | --720K | --720K |
| Total non current assets | --0 | 44.86%1.04M | 544.14%4.95M | 616.86%28.24M | 616.86%28.24M | 910.29%27.4M | -77.06%720K | 6.67%768K | -24.40%3.94M | -24.40%3.94M |
| Total assets | -36.49%97.69M | 9.66%108.48M | 33.13%121.26M | 35.28%138.74M | 35.28%138.74M | 39.82%153.81M | -17.57%98.93M | -24.41%91.08M | 57.02%102.56M | 57.02%102.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -64.92%1.71M | -39.80%1.89M | -31.37%2.43M | 26.11%2.68M | 26.11%2.68M | 238.68%4.88M | 94.23%3.13M | 35.88%3.55M | 99.62%2.12M | 99.62%2.12M |
| -accounts payable | -64.92%1.71M | -39.80%1.89M | -31.37%2.43M | 26.11%2.68M | 26.11%2.68M | 238.68%4.88M | 94.23%3.13M | 35.88%3.55M | 99.62%2.12M | 99.62%2.12M |
| Current accrued expenses | -27.53%4.92M | -9.31%5.84M | 63.03%6.91M | 135.50%6.68M | 135.50%6.68M | 276.18%6.79M | 257.55%6.44M | 101.86%4.24M | 102.79%2.84M | 102.79%2.84M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%13K | 6.25%34K | --53K | --53K |
| -Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | 0.00%13K | 6.25%34K | --53K | --53K |
| Other current liabilities | 30.64%1.28M | 18,533.33%559K | 6,320.00%321K | 11,033.33%668K | 11,033.33%668K | 12,100.00%976K | -66.67%3K | -50.00%5K | -64.71%6K | -64.71%6K |
| Current liabilities | -32.50%10.02M | -9.26%10.13M | 24.48%10.66M | 95.42%14.04M | 95.42%14.04M | 234.81%14.84M | 169.00%11.16M | 68.39%8.57M | 111.66%7.19M | 111.66%7.19M |
| Non current liabilities | ||||||||||
| Derivative product liabilities | ---- | ---- | ---- | --0 | --0 | --0 | -75.00%1K | -83.33%1K | -84.62%2K | -84.62%2K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | -75.00%1K | -83.33%1K | -84.62%2K | -84.62%2K |
| Total liabilities | -32.50%10.02M | -9.27%10.13M | 24.47%10.66M | 95.37%14.04M | 95.37%14.04M | 234.59%14.84M | 168.77%11.16M | 68.21%8.57M | 110.92%7.19M | 110.92%7.19M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -44.12%-198.25M | -53.50%-185.51M | -62.85%-171.07M | -72.15%-154.46M | -72.15%-154.46M | -76.62%-137.56M | -81.61%-120.85M | -86.18%-105.05M | -89.35%-89.72M | -89.35%-89.72M |
| Paid-in capital | 3.31%285.81M | 36.01%283.89M | 50.00%281.62M | 50.37%278.88M | 50.37%278.88M | 50.36%276.65M | 14.21%208.73M | 9.16%187.74M | --185.47M | --185.47M |
| Gains losses not affecting retained earnings | 191.80%112K | 77.31%-27K | 130.29%53K | 173.53%275K | 173.53%275K | 77.45%-122K | 66.94%-119K | -10.76%-175K | -1,285.19%-374K | -1,285.19%-374K |
| Total stockholders'equity | -36.91%87.67M | 12.07%98.35M | 34.03%110.6M | 30.75%124.7M | 30.75%124.7M | 31.63%138.97M | -24.25%87.76M | -28.50%82.52M | 54.05%95.37M | 54.05%95.37M |
| Total equity | -36.91%87.67M | 12.07%98.35M | 34.03%110.6M | 30.75%124.7M | 30.75%124.7M | 31.63%138.97M | -24.25%87.76M | -28.50%82.52M | 54.05%95.37M | 54.05%95.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data